Gemcitabine Pharmacogenomics: Deoxycytidine Kinase and Cytidylate Kinase Gene Resequencing and Functional Genomics-Reference-Cited by-同舟云学术

Gemcitabine Pharmacogenomics: Deoxycytidine Kinase and Cytidylate Kinase Gene Resequencing and Functional Genomics

Published:2008-06-12 Issue:9 Volume:36 Page:1951-1959
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Kocabas Neslihan Aygun,Aksoy Pinar,Pelleymounter Linda L.,Moon Irene,Ryu Jeong-Seon,Gilbert Judith A.,Salavaggione Oreste Ezequel,Eckloff Bruce W.,Wieben Eric D.,Yee Vivien,Weinshilboum Richard M.,Ames Matthew M.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference38 articles.

1. Decreased resistance to gemcitabine (2′,2′-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase

2. CMP Kinase from Escherichia coli Is Structurally Related to Other Nucleoside Monophosphate Kinases

3. Potential use of antiviral l(−)nucleoside analogues for the prevention or treatment of viral associated cancers

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic Behavior and Ligand Binding Properties of the Wild Type Deoxycytidine Kinase and its Characterized Gemcitabine-Resistant Variant: A Bioinformatics and Computational Study;Journal of Computational Biophysics and Chemistry;2023-08-24

2. Recent advances in targeting myeloid-derived suppressor cells and their applications to radiotherapy;International Review of Cell and Molecular Biology;2023

3. Studying the Anti-Tumor Effects of siRNA Gene Silencing of Some Metabolic Genes in Pancreatic Ductal Adenocarcinoma;Current Molecular Pharmacology;2021-08

4. Gemcitabine nanoparticles promote antitumor immunity against melanoma;Biomaterials;2019-01

5. Molecular Markers for Treatment Response and Toxicity of Gemcitabine;Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy;2019